Leaflet NIMOTOP 10mg / 50ml solution for infusion

Product code:
W63887002
Quantity:
5
Indicated for:
hypertension
Route of administration:
infusion
Substance:
nimodipine (calcium channel blocker)
ATC
C08CA06 — Cardiovascular system | Selective calcium channel blockers with mainly vascular effects | Dihydropyridine derivatives
Nimodipine is a calcium channel blocker primarily used for the prevention and treatment of cerebral vasospasms associated with subarachnoid hemorrhage. It works by relaxing blood vessels in the brain, improving cerebral blood flow.

The medication is administered orally or intravenously, depending on the patient's condition. The dose and duration of treatment are determined by the physician based on the severity of the condition. Common side effects include dizziness, headaches, nausea, and low blood pressure.

Nimodipine is contraindicated in patients with hypersensitivity to the active substance or other calcium channel blockers. It should also be used with caution in patients with severe liver impairment.

This medication is essential for preventing severe neurological complications associated with subarachnoid hemorrhage, contributing to improved outcomes for affected patients.

General data about NIMOTOP 10mg / 50ml

Substance:
nimodipine
Date of latest medicines list:
01-06-2026
Product code:
W63887002
Concentration:
10mg / 50ml
Pharmaceutical form:
solution for infusion
Packing volume:
50ml
Product type:
Original
Price:
166.97 RON
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
BAYER AG - GERMANIA
Holder:
BAYER AG - GERMANIA
Number:
9416/2016/02
Shelf life:
4 years

Pharmaceutical forms available for nimodipine

Concentrations available for nimodipine

  • 10mg/50ml
  • 30mg